Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients
Osteoporosis is a common systemic bone disease caused by the imbalance between osteogenic activity and osteoclastic activity. Aged women are at higher risk of osteoporosis, partly because of estrogen deficiency. However, the underlying mechanism of how estrogen deficiency affects osteoclast activity...
Main Authors: | Yi-Xuan Deng, Wen-Ge He, Hai-Jun Cai, Jin-Hai Jiang, Yuan-Yuan Yang, Yan-Rong Dan, Hong-Hong Luo, Yu Du, Liang Chen, Bai-Cheng He |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.815245/full |
Similar Items
-
Interferon Regulatory Factor 4 (IRF4) Plays a Key Role in Osteoblast Differentiation of Postmenopausal Osteoporosis
by: Xuan Wu, et al.
Published: (2024-03-01) -
Identification of differentially expressed genes, signaling pathways and immune infiltration in postmenopausal osteoporosis by integrated bioinformatics analysis
by: Xiaoli Zhou, et al.
Published: (2024-01-01) -
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
by: Jiarui Li, et al.
Published: (2022-11-01) -
Matricellular Protein SMOC2 Potentiates BMP9-Induced Osteogenic Differentiation in Mesenchymal Stem Cells through the Enhancement of FAK/PI3K/AKT Signaling
by: Wen-Ge He, et al.
Published: (2023-01-01) -
4D label-free quantitative proteomics analysis to screen potential drug targets of Jiangu Granules treatment for postmenopausal osteoporotic rats
by: Haiming Lin, et al.
Published: (2022-11-01)